LONDON (Reuters) - Regulators have delayed approval of an H5N1 bird flu vaccine from GlaxoSmithKline, designed to be used in a pandemic. A spokesman for Britain's biggest drugmaker said the delay was not related to recent controversy over link...
Source: http://health.yahoo.net/news/s/nm/fda-delays-approval-of-gsk-bird-flu-vaccine
here found here more for more
No comments:
Post a Comment
Note: only a member of this blog may post a comment.